A B S T R A C T One cloned complementary DNA and one genomnic subclone were used to detect restriction fragment length polymorphism associated with the proa2(I) gene for human type I procollagen. The restriction fragments obtained from examination of 30-122 chromosomes confirmed previous indications that the proa2(I) gene is found in a single copy in the human haploid genome. One highly polymorphic site was detected with EcoRI in the 5'-half of the gene. The restriction site polymorphism at the site had an allelic frequency of 0.38, and it generated two fragments of 10.5 and 3.5 kilobase in homozygous individuals. The restriction fragment length polymorphism generated at the EcoRI site was used to study affected and nonaffected individuals in four generations of a family with an autosomal dominant form of osteogenesis imperfecta. The data demonstrated a linkage of the phenotype to a proa2(I) allele with a lod score of 2.41 at a recombination fraction (0) of 0. The data therefore provided presumptive evidence that osteogenesis imperfecta in this family is caused by a mutation in the proa2(I) gene or some contiguous region of the genome. The relatively high frequency of polymorphism at the EcoRI site makes it useful for studying a broad range of genetic disorders in which mutations in type I procollagen are suspected. In addition, the polymorphic site should provide useful markers for linkage
INTRODUCTION
Variations in base sequences in and around genes generate DNA fragments of varying length when genomic DNA from different individuals is cleaved with restriction endonucleases. The detection of such fragments of varying lengths, known as RFLP', was first used to examine the inheritance of specific alleles of mitochondrial and yeast genes (1) (2) (3) . Within the past several years, it has proven to be a powerful tool for the study of human genetic disorders such as sickle cell disease (4) (5) , thalassemias (6) , and human growth hormone deficiency (7, 8) .
Recently, clones of complementary (c)DNA and genomic DNA for type I procollagen have become available (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . Studies with these DNA have revealed some unique characteristics of the collagen genes such as a complex intron-exon structure (9-11), a high degree of nucleotide conservation in an area coding for the carbohydrate attachment site in the C-propeptide of the proa2(I) chain (16) , and transcription of each gene into several different messenger RNA (19) . Fur (16) . Because of the large number and large size of the intervening sequences in the gene, the Hf-32 probe hybridized to fragments spanning over 12 kilobase (kb) of the gene (Fig. 1) . The probe for the 5'-end of the gene consisted of two DNA fragments (NJ-3' and NJ-3'), which contained 6.75 kb of genomic DNA extending downstream from the codon for the amino acid residue 19 of the a2(I) chain (Fig. 1 ).
RFLP associated with the human proa2(I) gene. To search for RFLP associated with the 3'-half of the proa2(I) gene, leukocyte DNA from 61 individuals was cleaved with 11 restriction endonucleases and hybridized with Hf-32. The 61 individuals were randomly selected among members of our laboratory staff and other volunteers. The number of chromosomes examined with each restriction endonuclease varied from 82 to 122. As indicated in Table I Table I , the frequency of the polymorphic site for PstI is -0.01. To search for RFLP associated with the 5'-end of the gene, similar experiments were carried out with the combined probe NJ-3' and NJ-3'. A highly polymorphic site for EcoRI was detected at the 5'-end of the gene. DNA of individuals homozygous for the absence of the polymorphic site (-/-) generated one fragment of 14 kb (Fig. 2) . DNA from individuals homozygous for the presence of the polymorphic site (+/+) generated two fragments of 10.5 and 3.5 kb.
DNA from individuals heterozygous for the polymorphic site (+/-) generated three fragments of 14, 10.5, and 3.5 kb. Thus, we identified three different genotypes. Analysis of DNA from a normal family demonstrated that the polymorphic site segregated as an autosomal dominant trait (Fig. 2) . A total of 100 chromosomes were examined from randomly selected individuals, and the allelic frequency for the presence of the polymorphic site was 0.38. The three genotypes were in Hardy-Weinberg equilibrium with observed values close to the theoretical (P < 0.10).
To confirm the polymorphic nature of the EcoRI site, we digested DNA from individuals homozygous for the presence (+/+) or absence (-/-) of the polymorphic site with other enzymes mapped in the same Hybridization with Hf-32, a 2.2-kb cDNA (see Fig. 1 ).
t Polymorphic site found in one chromosome examined. region. Single digestions with the restriction endonucleases HindIII and XbaI, and double digestions with the enzymes EcoRI and HindIII produced fragments with sizes consistent with the map distances of the recognition sites in the same region of the gene (19) . Analysis of a family with OI. The RFLP generated at the EcoRI in the 5'-region of the gene was used to study a family with an autosomal dominant form of OI. Leukocyte DNA was obtained from 18 individuals in four generations (Fig. 3) . To a variable degree, affected individuals presented with fractures, dentinogenesis imperfecta, hearing loss, small joint laxity, and white sclerae. In generation I, the affected individual (1-2) was heterozygous (-/+) for the presence of the EcoRI site and the nonaffected (I-1) was homozygous for absence of the site (-/-). In the subsequent three generations the phenotype cosegregated with a proa2(I) allele bearing the EcoRI recognition site. The lod score was 2.41 at a recombination fraction (0) of 0, indicating strong linkage (21 (23) . In addition, RFLP generated by either of two restriction endonucleases, DdeI or MstII, has been used to identify directly the mutation in the #'-globin gene (4, 5) . In the case of the gene for human growth hormone, five polymorphic restriction sites with allelic frequencies ranging from 0.30 to 0.44 have been detected within '40 kb of genomic DNA (7, 8) . With the human insulin gene, extensive RFLP is found in the 5'-flanking region as a result of either insertions or deletions at a site -800 bases upstream from the gene (24) . The most common alteration is a 1.6-kb insertion, which has an allelic frequency of -0.20 in normal individuals, and a significantly higher frequency in diabetics who are noninsulin dependent. The probes used here made it possible to survey -25 kb of the proa2(I) gene for RFLP (Fig. 1) . Only one polymorphic site in one individual was found with the cDNA Hf-32, even though this probe hybridized to fragments spanning over 12 kb of the gene and a total of 210 bases were surveyed with 11 restriction endonucleases. It is possible, however, that additional polymorphic sites will be found as the same region is explored more extensively with additional restriction endonucleases or with genomic probes. In contrast, the polymorphic EcoRI site in the 5'-half of the gene had the very high allelic frequency of 0.38.
The data developed here rigorously confirm previous indications that the proa2(I) gene is found in a single copy in the human haploid genome (11, 25, 26) . All the fragments detected with the genomic probe were accounted for by the linear map developed from overlapping phage clones of the human proa2(I) gene (19) . Since the intervening and flanking sequences of highly homologous genes, such as the two a-globin genes (27) (28) (29) (30) . However, it has been difficult to generate definitive data about the molecular defects, because of the large size of both the genes and the proteins. Also, the assembly of the procollagen molecule involves at least 11 posttranslational enzymes, and defects in one or more of these can produce disorders of connective tissue. In addition, defects of genes for other components of connective tissue may well produce similar phenotypes. Therefore, data demonstrating linkage of clinical phenotypes to specific alleles should provide invaluable information for systematically defining the molecular basis of a variety of disorders of the extracellular matrix. It should also be noted that the relatively high frequency of the EcoRI RFLP associated with the proa2(I) gene can be used as molecular marker for linkage studies with other foci assigned on chromosome 7, a chromosome for which only a few markers are currently available. A partially characterized al-like collagen gene with a HindIII RFLP has recently been located on chromosome 7 (31) .
